CSL Limited announces the appointment of Deborah Waterhouse as CEO and Managing Director, with the transition set to take effect on 1 February 2027.
CSL Limited has officially announced a significant leadership transition, naming Deborah Waterhouse as the incoming CEO and Managing Director effective 1 February 2027. This appointment marks a major change in executive governance for the company, signaling a potential shift in long-term strategic priorities as the organization prepares for this transition period.
Deborah Waterhouse has been appointed as the Chief Executive Officer and Managing Director.
The appointment is effective from 1 February 2027.
CSL Limited has named Deborah Waterhouse as its new Chief Executive Officer and Managing Director, effective 1 February 2027. The leadership transition marks a significant change for the Australian biotechnology giant as it prepares for its next phase of strategic growth.
Deborah Waterhouse is scheduled to assume the role of CEO and Managing Director on 1 February 2027.